OBJECTIVE: Impaired quality of life is a significant problem for people with major depressive disorder and is often not addressed through symptom remediation alone. This study examines a new therapy for the treatment for depression that focuses on reducing hopelessness and increasing positive future anticipation, which are factors posited to contribute to quality of life. The new treatment was compared to depressed patients in the same setting treated with group cognitive behavioral therapy. DESIGN: This study used a quasi-experimental design to examine the differences between future directed therapy and cognitive behavioral therapy on improving quality of life in patients with major depressive disorder. The main variables assessed at pre and post-treatment were quality of life, depressive symptoms, and hopelessness. SETTING: Outpatient Department of Psychiatry Cedars-Sinai Medical Center Participants: Twenty-two patients completed the future directed therapy intervention and 20 patients completed the cognitive behavioral therapy intervention. MEASUREMENTS: Patient-reported outcomes were collected using the Quick Inventory of Depressive Symptoms, the Beck Hopelessness Scale, and the Quality of Life Enjoyment and Satisfaction Questionnaire-Short Form. RESULTS: Though both treatments were effective at improving depression, hopelessness and positive future anticipation, those patients treated with future directed therapy demonstrated significant improvements in quality of life (p=0.002) while those treated in the cognitive behavioral therapy group did not (p=0.463). The magnitude of change for the main variables was significantly larger in the future directed therapy group and change in hopelessness and change in positive anticipation predicted change in quality of life in the future directed therapy group but not the cognitive behavioral therapy group. CONCLUSIONS: Future directed therapy is a useful treatment for patients with major depressive disorder and quality of life impairment.
OBJECTIVE: Impaired quality of life is a significant problem for people with major depressive disorder and is often not addressed through symptom remediation alone. This study examines a new therapy for the treatment for depression that focuses on reducing hopelessness and increasing positive future anticipation, which are factors posited to contribute to quality of life. The new treatment was compared to depressedpatients in the same setting treated with group cognitive behavioral therapy. DESIGN: This study used a quasi-experimental design to examine the differences between future directed therapy and cognitive behavioral therapy on improving quality of life in patients with major depressive disorder. The main variables assessed at pre and post-treatment were quality of life, depressive symptoms, and hopelessness. SETTING:Outpatient Department of Psychiatry Cedars-Sinai Medical Center Participants: Twenty-two patients completed the future directed therapy intervention and 20 patients completed the cognitive behavioral therapy intervention. MEASUREMENTS: Patient-reported outcomes were collected using the Quick Inventory of Depressive Symptoms, the Beck Hopelessness Scale, and the Quality of Life Enjoyment and Satisfaction Questionnaire-Short Form. RESULTS: Though both treatments were effective at improving depression, hopelessness and positive future anticipation, those patients treated with future directed therapy demonstrated significant improvements in quality of life (p=0.002) while those treated in the cognitive behavioral therapy group did not (p=0.463). The magnitude of change for the main variables was significantly larger in the future directed therapy group and change in hopelessness and change in positive anticipation predicted change in quality of life in the future directed therapy group but not the cognitive behavioral therapy group. CONCLUSIONS: Future directed therapy is a useful treatment for patients with major depressive disorder and quality of life impairment.
Entities:
Keywords:
Major depressive disorder; cognitive behavioral therapy; future directed therapy; hopelessness; positive psychology; quality of life
Authors: Molly R. Fortner; Kristine Brown; Indu M. Varia; Kenneth R. Gersing; Christopher O'Connor; P Murali Doraiswamy Journal: Prim Care Companion J Clin Psychiatry Date: 1999-12
Authors: David L. Dunner; W Jacqueline Kwong; Trisha L. Houser; Nathalie E. Richard; Rafe M. J. Donahue; Zeba M. Khan Journal: Prim Care Companion J Clin Psychiatry Date: 2001-02
Authors: W W IsHak; J Mirocha; D James; G Tobia; J Vilhauer; H Fakhry; S Pi; E Hanson; R Nashawati; E D Peselow; R M Cohen Journal: Acta Psychiatr Scand Date: 2014-06-23 Impact factor: 6.392
Authors: Rebecca M Schwartz; Kathleen M Weber; Gabrielle E Schechter; Nina C Connors; Yolene Gousse; Mary A Young; Mardge H Cohen Journal: AIDS Patient Care STDS Date: 2014-04-11 Impact factor: 5.078
Authors: Christina A Brezing; C Jean Choi; Martina Pavlicova; Daniel Brooks; Amy L Mahony; John J Mariani; Frances R Levin Journal: Am J Addict Date: 2018-02-19
Authors: Jason C Nellis; Masaru Ishii; Patrick J Byrne; Kofi D O Boahene; Jacob K Dey; Lisa E Ishii Journal: JAMA Facial Plast Surg Date: 2017-05-01 Impact factor: 4.611